InfuSystem Holdings, Inc (NYSE: INFU)

InfuSystem Holdings, Inc. is a leading national healthcare service provider facilitating outpatient care for Durable Medical Equipment manufacturers and healthcare providers. The company delivers products and services enabling clinic-to-home healthcare solutions, particularly for complex DME requiring ongoing treatment. Its operations are centered on two core platforms: Patient Services and Device Solutions, which together support healthcare providers in managing infusion therapies and related equipment needs across outpatient settings.

InfuSystem Holdings, Inc. generates revenue primarily through the rental, sale, and servicing of ambulatory and pole-mounted infusion pumps, along with associated disposable supply kits and biomedical services. Revenue is derived from billing third-party payers, healthcare facilities, and patients for the use of equipment and related consumables, including chemotherapy infusion supplies and wound care products. The company serves hospitals, oncology practices, ambulatory surgery centers, home care providers, and other alternate site healthcare providers across the United States and Canada.

The company operates through the following segments: Patient Services and Device Solutions.

• Patient Services: This segment focuses on delivering turnkey clinic-to-home healthcare solutions involving Durable Medical Equipment, including electronic ambulatory infusion pumps and associated disposable supply kits. The leading service within this segment is the Oncology Business, which supplies pumps and kits to private oncology clinics, infusion clinics, and hospital outpatient oncology clinics for cancer treatment. In 2025, the Oncology Business generated approximately 87% of the Patient Services segment’s net revenues, with 43% from colorectal cancer treatments and 44% from non-colorectal disease states. The segment also provides pain management services using continuous peripheral nerve block therapy, Negative Pressure Wound Therapy devices from manufacturers such as Smith and Nephew, Cork Medical LLC, and Genadyne Biotechnologies Inc., and Pneumatic Compression Devices. Additional activities include pursuing acquisitions of regional healthcare service providers, forming partnerships like SI Healthcare Technologies LLC with Sanara MedTech Inc., and offering information technology-based services such as EXPRESS, InfuConnect, DeviceHub, BlockPain Dashboard®, and Tracking Inhouse Management to streamline billing and clinical operations.

• Device Solutions: This segment provides rental, sale, and leasing services for new and pre-owned pole-mounted and ambulatory infusion pumps, along with treatment-related consumables. It also offers biomedical recertification, maintenance, and repair services for infusion pumps and other DME equipment used by oncology practices, hospitals, home care providers, skilled nursing facilities, and pain centers. The segment includes servicing equipment acquired through acquisitions such as FilAMed and OB Healthcare Corporation, which expanded its biomedical service capabilities. As of December 31, 2025, the rental fleet had a historical cost of $109.1 million and included approximately 96 makes and models of equipment, while the fleet held for sale or rental was valued at $4.6 million. The company operates biomedical service Centers of Excellence, including a primary facility in Lenexa, Kansas, and deploys field-based and traveling technicians to provide on-site maintenance and repair services nationwide.

InfuSystem Holdings, Inc. holds a strong position in the Durable Medical Equipment industry, particularly in outpatient oncology infusion services, where it leverages long-standing relationships with healthcare providers and a broad network of third-party payer contracts. The company competes with national, regional, and hospital-owned DME providers, physician-owned infusion services, and home care infusion companies. Competitive advantages include its extensive third-party payer network—nearly 840 contracts as of December 31, 2025—economies of scale in pump procurement and management, a large and responsive fleet of infusion pumps, seven geographic locations enabling rapid delivery, and a skilled biomedical service team. These barriers to entry are reinforced by the company’s reputation for high service levels and its focus on revenue cycle management and clinical support.

InfuSystem Holdings, Inc. serves hospitals, oncology practices, ambulatory surgery centers, home care providers, skilled nursing facilities, pain centers, and other alternate site healthcare providers. The company maintains business relationships with clinical oncologists in approximately 2,100 outpatient oncology clinics as of December 31, 2025. No single payer or customer accounted for more than 10% of net revenue in 2025 or 2024, indicating a diversified customer base across various healthcare settings and payer types, including Medicare, Medicaid, commercial insurers, and self-insured plans.